Logo image of ALENO.PA

ENOGIA SAS (ALENO.PA) Stock Fundamental Analysis

EPA:ALENO - Euronext Paris - Matif - FR0014004974 - Common Stock - Currency: EUR

3.14  -0.03 (-0.95%)

Fundamental Rating

2

Overall ALENO gets a fundamental rating of 2 out of 10. We evaluated ALENO against 56 industry peers in the Electrical Equipment industry. Both the profitability and financial health of ALENO have multiple concerns. While showing a medium growth rate, ALENO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALENO had negative earnings in the past year.
ALENO had negative earnings in each of the past 5 years.
In the past 5 years ALENO always reported negative operating cash flow.
ALENO.PA Yearly Net Income VS EBIT VS OCF VS FCFALENO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

ALENO has a Return On Assets of -4.40%. This is in the lower half of the industry: ALENO underperforms 64.29% of its industry peers.
The Return On Equity of ALENO (-12.48%) is worse than 64.29% of its industry peers.
Industry RankSector Rank
ROA -4.4%
ROE -12.48%
ROIC N/A
ROA(3y)-15.16%
ROA(5y)-16.28%
ROE(3y)-43.3%
ROE(5y)-107.28%
ROIC(3y)N/A
ROIC(5y)N/A
ALENO.PA Yearly ROA, ROE, ROICALENO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 75.30%, ALENO belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
ALENO's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALENO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y-12.18%
ALENO.PA Yearly Profit, Operating, Gross MarginsALENO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

ALENO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALENO remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALENO has more shares outstanding
The debt/assets ratio for ALENO is higher compared to a year ago.
ALENO.PA Yearly Shares OutstandingALENO.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2M 4M 6M
ALENO.PA Yearly Total Debt VS Total AssetsALENO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

ALENO has an Altman-Z score of 1.07. This is a bad value and indicates that ALENO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.07, ALENO is doing worse than 64.29% of the companies in the same industry.
A Debt/Equity ratio of 0.72 indicates that ALENO is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.72, ALENO is doing worse than 67.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACCN/A
WACC7.53%
ALENO.PA Yearly LT Debt VS Equity VS FCFALENO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

ALENO has a Current Ratio of 1.54. This is a normal value and indicates that ALENO is financially healthy and should not expect problems in meeting its short term obligations.
ALENO has a Current ratio (1.54) which is comparable to the rest of the industry.
A Quick Ratio of 1.53 indicates that ALENO should not have too much problems paying its short term obligations.
The Quick ratio of ALENO (1.53) is better than 76.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.53
ALENO.PA Yearly Current Assets VS Current LiabilitesALENO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.77% over the past year.
Looking at the last year, ALENO shows a very strong growth in Revenue. The Revenue has grown by 57.98%.
ALENO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.85% yearly.
EPS 1Y (TTM)60.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.33%
Revenue 1Y (TTM)57.98%
Revenue growth 3Y39.7%
Revenue growth 5Y25.85%
Sales Q2Q%62.16%

3.2 Future

Based on estimates for the next years, ALENO will show a very strong growth in Earnings Per Share. The EPS will grow by 123.61% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2Y123.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALENO.PA Yearly Revenue VS EstimatesALENO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALENO.PA Yearly EPS VS EstimatesALENO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2026 0 0.5 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALENO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALENO.PA Price Earnings VS Forward Price EarningsALENO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALENO.PA Per share dataALENO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

ALENO's earnings are expected to grow with 123.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y123.61%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALENO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENOGIA SAS

EPA:ALENO (6/18/2025, 7:00:00 PM)

3.14

-0.03 (-0.95%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.52%
Inst Owner ChangeN/A
Ins Owners26.37%
Ins Owner ChangeN/A
Market Cap19.75M
Analysts86.67
Price Target3.26 (3.82%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.46
P/FCF N/A
P/OCF N/A
P/B 2.55
P/tB 23.51
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.27
BVpS1.23
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.4%
ROE -12.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.3%
FCFM N/A
ROA(3y)-15.16%
ROA(5y)-16.28%
ROE(3y)-43.3%
ROE(5y)-107.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5Y-12.18%
F-ScoreN/A
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.53
Altman-Z 1.07
F-ScoreN/A
WACC7.53%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.33%
EPS Next Y100%
EPS Next 2Y123.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)57.98%
Revenue growth 3Y39.7%
Revenue growth 5Y25.85%
Sales Q2Q%62.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A